223 related articles for article (PubMed ID: 12093893)
1. Increased C5a receptor expression in sepsis.
Riedemann NC; Guo RF; Neff TA; Laudes IJ; Keller KA; Sarma VJ; Markiewski MM; Mastellos D; Strey CW; Pierson CL; Lambris JD; Zetoune FS; Ward PA
J Clin Invest; 2002 Jul; 110(1):101-8. PubMed ID: 12093893
[TBL] [Abstract][Full Text] [Related]
2. Protective effects of IL-6 blockade in sepsis are linked to reduced C5a receptor expression.
Riedemann NC; Neff TA; Guo RF; Bernacki KD; Laudes IJ; Sarma JV; Lambris JD; Ward PA
J Immunol; 2003 Jan; 170(1):503-7. PubMed ID: 12496437
[TBL] [Abstract][Full Text] [Related]
3. Neutrophil C5a receptor and the outcome in a rat model of sepsis.
Guo RF; Riedemann NC; Bernacki KD; Sarma VJ; Laudes IJ; Reuben JS; Younkin EM; Neff TA; Paulauskis JD; Zetoune FS; Ward PA
FASEB J; 2003 Oct; 17(13):1889-91. PubMed ID: 12897064
[TBL] [Abstract][Full Text] [Related]
4. C5a receptor and thymocyte apoptosis in sepsis.
Riedemann NC; Guo RF; Laudes IJ; Keller K; Sarma VJ; Padgaonkar V; Zetoune FS; Ward PA
FASEB J; 2002 Jun; 16(8):887-8. PubMed ID: 12039868
[TBL] [Abstract][Full Text] [Related]
5. Evidence for a functional role of the second C5a receptor C5L2.
Gao H; Neff TA; Guo RF; Speyer CL; Sarma JV; Tomlins S; Man Y; Riedemann NC; Hoesel LM; Younkin E; Zetoune FS; Ward PA
FASEB J; 2005 Jun; 19(8):1003-5. PubMed ID: 15784721
[TBL] [Abstract][Full Text] [Related]
6. Protection of innate immunity by C5aR antagonist in septic mice.
Huber-Lang MS; Riedeman NC; Sarma JV; Younkin EM; McGuire SR; Laudes IJ; Lu KT; Guo RF; Neff TA; Padgaonkar VA; Lambris JD; Spruce L; Mastellos D; Zetoune FS; Ward PA
FASEB J; 2002 Oct; 16(12):1567-74. PubMed ID: 12374779
[TBL] [Abstract][Full Text] [Related]
7. Anti-complement strategies in experimental sepsis.
Ward PA; Riedemann NC; Guo RF; Huber-Lang M; Sarma JV; Zetoune FS
Scand J Infect Dis; 2003; 35(9):601-3. PubMed ID: 14620141
[TBL] [Abstract][Full Text] [Related]
8. Role of C5a-C5aR interaction in sepsis.
Guo RF; Riedemann NC; Ward PA
Shock; 2004 Jan; 21(1):1-7. PubMed ID: 14676676
[TBL] [Abstract][Full Text] [Related]
9. Expression of the anaphylatoxin C5a receptor in non-myeloid cells.
Zwirner J; Fayyazi A; Götze O
Mol Immunol; 1999; 36(13-14):877-84. PubMed ID: 10698342
[TBL] [Abstract][Full Text] [Related]
10. Expression of the complement C5a anaphylatoxin receptor (C5aR) on non-myeloid cells.
Wetsel RA
Immunol Lett; 1995 Jan; 44(2-3):183-7. PubMed ID: 7797249
[TBL] [Abstract][Full Text] [Related]
11. Enhanced expression of complement C5a receptor mRNA in human diseased kidney assessed by in situ hybridization.
Abe K; Miyazaki M; Koji T; Furusu A; Nakamura-Kurashige T; Nishino T; Ozono Y; Harada T; Sakai H; Kohno S
Kidney Int; 2001 Jul; 60(1):137-46. PubMed ID: 11422745
[TBL] [Abstract][Full Text] [Related]
12. Regulatory role of C5a in LPS-induced IL-6 production by neutrophils during sepsis.
Riedemann NC; Guo RF; Hollmann TJ; Gao H; Neff TA; Reuben JS; Speyer CL; Sarma JV; Wetsel RA; Zetoune FS; Ward PA
FASEB J; 2004 Feb; 18(2):370-2. PubMed ID: 14688199
[TBL] [Abstract][Full Text] [Related]
13. C5a, a therapeutic target in sepsis.
Guo RF; Ward PA
Recent Pat Antiinfect Drug Discov; 2006 Jan; 1(1):57-65. PubMed ID: 18221134
[TBL] [Abstract][Full Text] [Related]
14. C5a receptor and interleukin-6 are expressed in tissue macrophages and stimulated keratinocytes but not in pulmonary and intestinal epithelial cells.
Fayyazi A; Sandau R; Duong LQ; Götze O; Radzun HJ; Schweyer S; Soruri A; Zwirner J
Am J Pathol; 1999 Feb; 154(2):495-501. PubMed ID: 10027407
[TBL] [Abstract][Full Text] [Related]
15. Sepsis, apoptosis and complement.
Ward PA
Biochem Pharmacol; 2008 Dec; 76(11):1383-8. PubMed ID: 18848819
[TBL] [Abstract][Full Text] [Related]
16. Cellular expression of the C5a anaphylatoxin receptor (C5aR): demonstration of C5aR on nonmyeloid cells of the liver and lung.
Haviland DL; McCoy RL; Whitehead WT; Akama H; Molmenti EP; Brown A; Haviland JC; Parks WC; Perlmutter DH; Wetsel RA
J Immunol; 1995 Feb; 154(4):1861-9. PubMed ID: 7836770
[TBL] [Abstract][Full Text] [Related]
17. cDNA cloning and characterization of rat C5a anaphylatoxin receptor.
Akatsu H; Miwa T; Sakurada C; Fukuoka Y; Ember JA; Yamamoto T; Hugli TE; Okada H
Microbiol Immunol; 1997; 41(7):575-80. PubMed ID: 9272704
[TBL] [Abstract][Full Text] [Related]
18. Complement factor C5a mediates renal ischemia-reperfusion injury independent from neutrophils.
de Vries B; Köhl J; Leclercq WK; Wolfs TG; van Bijnen AA; Heeringa P; Buurman WA
J Immunol; 2003 Apr; 170(7):3883-9. PubMed ID: 12646657
[TBL] [Abstract][Full Text] [Related]
19. C5aR, TNF-α, and FGL2 contribute to coagulation and complement activation in virus-induced fulminant hepatitis.
Liu J; Tan Y; Zhang J; Zou L; Deng G; Xu X; Wang F; Ma Z; Zhang J; Zhao T; Liu Y; Li Y; Zhu B; Guo B
J Hepatol; 2015 Feb; 62(2):354-62. PubMed ID: 25200905
[TBL] [Abstract][Full Text] [Related]
20. An essential role for complement C5a in the pathogenesis of septic cardiac dysfunction.
Niederbichler AD; Hoesel LM; Westfall MV; Gao H; Ipaktchi KR; Sun L; Zetoune FS; Su GL; Arbabi S; Sarma JV; Wang SC; Hemmila MR; Ward PA
J Exp Med; 2006 Jan; 203(1):53-61. PubMed ID: 16380509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]